DNA Damage Atlas |
Basic Information
Dataset ID:
 GSE140372
PMID:
 32057297
Technique Type:
 END-seq
Publication:
 Suppressing proteasome mediated processing of topoisomerase II DNA-protein complexes preserves genome integrity
First Author:
 Nicholas Sciascia
Last Author:
 André Nussenzweig
Year:
 2020
Journal:
 eLife
Access Link:  
Samples ( 35 )
Sample Name | Cell Line/Tissue | Organism | Treatment | Genotype | In-situ Treatment | Cell Phase | Bait/Targeted Break | Technique | fastqc |
GSM4160241-NT | Primary B cell | Mus musculus | NT | WT | Exo VII + Exo T | G1 | / | END-seq | |
GSM4160242-ETO | Primary B cell | Mus musculus | Etoposide | WT | Exo VII + Exo T | G1 | / | END-seq | |
GSM4160243-ETO_WO | Primary B cell | Mus musculus | Etoposide | WT | Exo VII + Exo T | G1 | / | END-seq | |
GSM4160244-ETO_WO_2h | Primary B cell | Mus musculus | Etoposide | WT | Exo VII + Exo T | G1 | / | END-seq | |
GSM4160245-BTZ | Primary B cell | Mus musculus | Bortezomib | WT | Exo VII + Exo T | G1 | / | END-seq | |
GSM4160246-ETO--BTZ | Primary B cell | Mus musculus | Etoposide + Bortezomib | WT | Exo VII + Exo T | G1 | / | END-seq | |
GSM4160247-ETO--BTZ_WO | Primary B cell | Mus musculus | Etoposide + Bortezomib | WT | Exo VII + Exo T | G1 | / | END-seq | |
GSM4160248-ETO--BTZ_WO_2h | Primary B cell | Mus musculus | Etoposide + Bortezomib | WT | Exo VII + Exo T | G1 | / | END-seq | |
GSM4160249-ETO_Exo7--ExoT | Primary B cell | Mus musculus | Etoposide | WT | Exo VII + Exo T | G1 | / | END-seq | |
GSM4160250-ETO_ExoT | Primary B cell | Mus musculus | Etoposide | WT | Exo T | G1 | / | END-seq | |
GSM4160251-ETO_WO_Exo7--ExoT | Primary B cell | Mus musculus | Etoposide | WT | Exo VII + Exo T | G1 | / | END-seq | |
GSM4160252-ETO_WO_ExoT | Primary B cell | Mus musculus | Etoposide | WT | Exo T | G1 | / | END-seq | |
GSM4160253-ETO--BTZ_Exo7--ExoT | Primary B cell | Mus musculus | Etoposide + Bortezomib | WT | Exo VII + Exo T | G1 | / | END-seq | |
GSM4160254-ETO--BTZ_ExoT | Primary B cell | Mus musculus | Etoposide + Bortezomib | WT | Exo T | G1 | / | END-seq | |
GSM4160255-ETO--BTZ_WO_Exo7--ExoT | Primary B cell | Mus musculus | Etoposide + Bortezomib | WT | Exo VII + Exo T | G1 | / | END-seq | |
GSM4160256-ETO--BTZ_WO_ExoT | Primary B cell | Mus musculus | Etoposide + Bortezomib | WT | Exo T | G1 | / | END-seq | |
GSM4160257-pre-BTZ--ETO | Primary B cell | Mus musculus | pre-Bortezomib + Etoposide | WT | Exo VII + Exo T | G1 | / | END-seq | |
GSM4160258-pre-BTZ--ETO_WO_2h | Primary B cell | Mus musculus | pre-Bortezomib + Etoposide | WT | Exo VII + Exo T | G1 | / | END-seq | |
GSM4160259-co-BTZ--ETO | Primary B cell | Mus musculus | Etoposide co-treatment with Bortezomib | WT | Exo VII + Exo T | G1 | / | END-seq | |
GSM4160260-co-BTZ--ETO_WO_2h | Primary B cell | Mus musculus | Etoposide co-treatment with Bortezomib | WT | Exo VII + Exo T | G1 | / | END-seq | |
GSM4160261-post-BTZ--ETO_WO_2h | Primary B cell | Mus musculus | Etoposide post-treatment with Bortezomib | WT | Exo VII + Exo T | G1 | / | END-seq | |
GSM4160262-no_BTZ--ETO | Primary B cell | Mus musculus | Etoposide | WT | Exo VII + Exo T | G1 | / | END-seq | |
GSM4160263-no_BTZ--ETO_WO_2h | Primary B cell | Mus musculus | Etoposide | WT | Exo VII + Exo T | G1 | / | END-seq | |
GSM4160264-WT_ETO_Exo7--ExoT | Primary B cell | Mus musculus | Etoposide | WT | Exo VII + Exo T | G1 | / | END-seq | |
GSM4160265-RNF4_ETO_Exo7--ExoT | Primary B cell | Mus musculus | Etoposide | RNF4-/- | Exo VII + Exo T | G1 | / | END-seq | |
GSM4160266-WT_ETO_ExoT_only | Primary B cell | Mus musculus | Etoposide | WT | Exo T | G1 | / | END-seq | |
GSM4160267-RNF4_ETO_ExoT_only | Primary B cell | Mus musculus | Etoposide | RNF4-/- | Exo T | G1 | / | END-seq | |
GSM4207022-NT_rep2 | Primary B cell | Mus musculus | NT | WT | Exo VII + Exo T | G1 | / | END-seq | |
GSM4207023-ETO_rep2 | Primary B cell | Mus musculus | Etoposide | WT | Exo VII + Exo T | G1 | / | END-seq | |
GSM4207024-ETO_WO_rep2 | Primary B cell | Mus musculus | Etoposide | WT | Exo VII + Exo T | G1 | / | END-seq | |
GSM4207025-ETO_WO_2h_rep2 | Primary B cell | Mus musculus | Etoposide | WT | Exo VII + Exo T | G1 | / | END-seq | |
GSM4207026-BTZ_rep2 | Primary B cell | Mus musculus | Bortezomib | WT | Exo VII + Exo T | G1 | / | END-seq | |
GSM4207027-ETO--BTZ_rep2 | Primary B cell | Mus musculus | Etoposide + Bortezomib | WT | Exo VII + Exo T | G1 | / | END-seq | |
GSM4207028-ETO--BTZ_WO_rep2 | Primary B cell | Mus musculus | Etoposide + Bortezomib | WT | Exo VII + Exo T | G1 | / | END-seq | |
GSM4207029-ETO--BTZ_WO_2h_rep2 | Primary B cell | Mus musculus | Etoposide + Bortezomib | WT | Exo VII + Exo T | G1 | / | END-seq |
Copyright © 2023 All Rights Reserved by Wu lab